Neko Health is reimagining preventive medicine around AI-driven full-body health scans. In a single appointment lasting minutes, the company's scanning stations capture millions of data points across a patient's skin, cardiovascular system, and circulation, which are then analyzed using AI to surface potential health issues early, before symptoms appear.
The company's thesis is that healthcare is overwhelmingly reactive, and that high-resolution, AI-assisted screening can shift care toward prevention. Each scan produces a detailed, longitudinal health picture that patients review with a clinician, building a baseline that can be tracked over time across repeat visits.
Founded in 2018 and publicly launched in 2023, Neko Health is headquartered in Stockholm, Sweden, and was co-founded by Hjalmar Nilsonne (CEO) and Daniel Ek, the founder of Spotify. The company has opened clinics in Stockholm and London and plans further expansion across Europe and into the US.
Neko Health raised a $260 million Series B announced in January 2025, led by Lightspeed Venture Partners with participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico. This followed a roughly $65 million Series A. The funding supports US and European expansion and investment in diagnostics.
Neko positions itself as a new category of preventive health provider, pairing proprietary scanning hardware with AI analysis and an in-person clinical experience.
